For Investors · Series A
Currently raising

Investing in healthcare innovation and access.

LifePulse is transforming cardiac diagnostics with AI, starting with ECG analysis, then expanding across the medical diagnostic spectrum. Series A is open.

Request data room → See the opportunity
$187B
AI-driven healthcare market by 2030
46%
of rural US hospitals operate without a cardiologist
122M
Americans where cardiac specialists are scarce
20min
Average ER ECG interpretation wait time today
The opportunity

A care gap measured in minutes, lives, and ZIP codes.

Cardiovascular disease remains the leading cause of death worldwide, yet for tens of millions of Americans, the specialist who reads an ECG isn't down the hall. They aren't in the building. Often they aren't in the county.

In emergencies, every minute lost waiting for a read costs cardiac muscle. We close that gap with AI that's already as good as a specialist, available immediately, anywhere there's a network.

  • Nearly 46% of rural hospitals operate without a cardiologist.
  • Over 122 million Americans live where cardiac specialists are scarce.
  • 60% of rural residents lack regular access to specialized cardiac care.
  • Emergency ECG reads average over 20 minutes.
  • Cardiovascular disease remains the #1 cause of death globally.
Market potential

A $187B shift toward accessible diagnostics.

Multiple converging markets, ECG hardware, rural healthcare tech, telemedicine, and AI-driven diagnostics, all expanding into the same gap.

$40B

Global ECG devices market

Projected to reach $40B by 2031 as digital ECG hardware proliferates into primary care and home settings.

$20B

Rural healthcare technology

A $20B market expanding alongside federal investment in rural broadband and care infrastructure.

35% CAGR

Telemedicine growth

Expanding 35% annually, the rails our AI diagnostic layer is built to ride.

$187B

AI-driven healthcare

Expected to be a $187B industry by 2030, the macro tailwind for every algorithm we ship.

Business model

Subscription SaaS, scalable, sticky, and high-margin.

Per-site or per-recording pricing for clinics, per-seat for research labs. Recurring revenue from day one, with expansion built in as we add diagnostic modalities.

Life-saving impact

Beyond market potential, the lives in the gap.

When AI-grade cardiac analysis is universally available, the outcomes compound across every demographic and ZIP code.

2,000+ rural hospitals

Provide direct access in facilities currently operating without a cardiologist on site.

Minutes → seconds

Cut diagnostic wait times from minutes to seconds, restoring time-critical decision making.

24/7 cardiac expertise

Specialist-grade reads available at 3am in a county hospital, same quality as a metro stroke center.

Earlier detection

Move arrhythmia detection upstream, reducing long-term healthcare costs and morbidity.

Better emergency outcomes

Faster, more accurate triage where every minute affects survival rate.

Health equity, measurable

Outcomes tracked by ZIP code, close the urban/rural cardiac-survival gap, then prove it.

Competitive advantage

We don't fine-tune for medicine. We build for it.

Proprietary architecture, modular by design, and HIPAA-native from the database layer up.

01 · Technical innovation

A custom transformer for cardiac signals.

Proprietary 1D Patch Transformer architecture, trained on the hardest cardiac signals in electrophysiology. Modular design lets us expand into new diagnostic domains without retraining from zero. HIPAA-compliant by construction.

02 · Scalability & expansion

ECG today. The full diagnostic spectrum next.

Starting with ECG, then medical imaging, lab diagnostics, clinical decision support, and preventive analytics. Our team has built million-participant research systems and multi-million-user telecom infrastructure, we scale where most healthtech startups fold.

Traction

We're not asking you to back a slide. We're asking you to scale what already works.

01 · Model

Meeting or exceeding expert analysis

Proprietary transformer model validated in active preclinical research with university partners. R-peak detection at sub-millisecond precision.

02 · Platform

Live research platform (Jerry)

Processing 24-hour mouse ECG recordings, 600,000+ heartbeats detected in ~90 seconds. Used today, in production, by research partners.

03 · Economics

90% cost reduction in compute

Infrastructure optimized down from initial deployment cost, scalable cloud architecture that compounds gross margin as we grow.

04 · Pipeline

Cross-species expansion underway

Active drug-study analysis supporting real cardiac research. Human ECG validation pipeline now in motion.

Strategic roadmap

Ambitious milestones, set on real progress.

M1 · Validation

Complete clinical validation

Full validation cycle with our research & clinical healthcare hospital system partner.

M2 · Regulatory

Secure necessary approvals

Pursue and secure regulatory approvals required for clinical deployment in the US.

M3 · Pilot

Launch underserved-area pilots

First clinical pilot programs in rural facilities currently operating without on-site cardiology.

M4 · Device partner

Medical-devices pilot

Launch pilot program with a medical-devices partner, embedded AI on existing ECG hardware.

M5 · Team

Expand the technical team

Hire ML engineers, clinical informatics, and rural-deployment specialists to accelerate the next phase.

Use of funds

Where the capital goes

~60% engineering & clinical validation · ~25% regulatory and quality · ~15% commercial pilots.

Leadership team

Deep expertise in AI, healthcare, and growth.

"We've built systems that handle a million participants and telecom networks that handle hundreds of millions of users. The technical risk in cardiac AI is real, but it's risk we know how to absorb."
Joel Zamboni
Joel Zamboni
CAIO & Co-founder · AI strategy & engineering
"Thirty years operating engineering teams taught me the same lesson healthcare keeps trying to learn: scale only matters if it reaches the people the system currently fails. That's our compass."
Dean Heistad
Dean Heistad
CEO & Co-founder · 30y operations & engineering
Investor data room

Everything you need to underwrite, in one secure room.

Series A Preferred Stock. Board representation opportunities. Clear exit strategy. Submit the form and our IR team will provision access to the full data room, pitch deck, financial model, technical documentation, market analysis, and impact metrics.

Series A Pitch Deck
PDF · 28 slides · 12 MB
→
5-year financial model
XLSX · revenue + cost + unit econ
→
Technical documentation
Architecture · model card · validation
→
Market & impact analysis
TAM · SAM · social impact dossier
→
Cap table & term sheet
Series A Preferred · standard terms
→
Investor relations

Have questions before requesting the data room?

Our IR team will follow up directly. Diligence calls available on request.

contact@lifepulse.ai → Connect on LinkedIn